Development and Validation of a Machine Learning Algorithm for Predicting Response to Anticholinergic Medications for Overactive Bladder Syndrome

Overactive Bladder

Increased risk of dementia among overactive bladder patients treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study

BJU Int.

Welk B, McArthur E

doi: 10.1111/bju.15040.

Overactive BladderMenopause

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause

Eur J Obstet Gynecol Reprod Biol.

Matarazzo MG, Caruso S, Giunta G, Valenti G, Sarpietro G, Cianci A

doi: 10.1016/j.ejogrb.2018.01.002.

Overactive Bladder

Beyond the bladder: poor sleep in women with overactive bladder syndrome

Am J Obstet Gynecol.

Savoie MB, Lee KA, Subak LL, Hernandez C, Schembri M, Fung CH, Grady D, Huang AJ

doi: 10.1016/j.ajog.2019.12.005.

Pregnancy and Childbirth

Prediction of vaginal birth after cesarean deliveries using machine learning

Am J Obstet Gynecol.

Lipschuetz M, Joshua Guedalia, Rottenstreich A, Novoselsky Persky M, Cohen MSM, Kabiri D, Levin G, Yagel S, Unger R, Sompolinsky Y

doi: 10.1016/j.ajog.2019.12.267.

Overactive Bladder

Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?

Eur Urol Focus.

Marcelissen T, Rashid T, Antunes Lopes T, Delongchamps NB, Geavlete B, Rieken M, Cornu JN, Rahnama'i MS

doi: 10.1016/j.euf.2018.03.011.

Overactive BladderUrinary Tract Infections (UTI)

Onabotulinum toxin A in children with refractory idiopathic overactive bladder: medium-term outcomes

J Pediatr Urol.

Ingham J, Angotti R, Lewis M, Goyal A

doi: 10.1016/j.jpurol.2018.08.007.

Overactive Bladder

Treatment Response and Complications after Intradetrusor Onabotulinumtoxin A Injection in Male Patients with Idiopathic Overactive Bladder Syndrome

J Urol.

Arrom LM, Ferrer OM, Rubio LS, Ruiz CG, Barea VM, Redorta JP, Smet CE

doi: 10.1097/JU.0000000000000525.

Overactive Bladder

Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sjögren syndrome

Lupus.

Pereira E Silva R, Romão VC, Neves M, Garcia R, Oliveira S, Brites J, Ramos FO, Canhão H, Palma Dos Reis J, Pereira da Silva JA, Lopes T

doi: 10.1177/0961203318811605.

Overactive BladderUrinary Tract Infections (UTI)

Predictive Factors of De Novo Overactive Bladder after Artificial Urinary Sphincter Implantation in Men with Post-Prostatectomy Incontinence

Urology.

Ko KJ, Lee CU, Kim TH, Suh YS, Lee KS

doi: 10.1016/

Related content

Increased risk of dementia among overactive bladder patients treated with an anticholinergic medication compared to a beta-3 agonist: a population-based cohort study

Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause

Beyond the bladder: poor sleep in women with overactive bladder syndrome

Prediction of vaginal birth after cesarean deliveries using machine learning

Oral Pharmacologic Management of Overactive Bladder Syndrome: Where Do We Stand?

Onabotulinum toxin A in children with refractory idiopathic overactive bladder: medium-term outcomes

Treatment Response and Complications after Intradetrusor Onabotulinumtoxin A Injection in Male Patients with Idiopathic Overactive Bladder Syndrome

Overactive bladder symptom bother and health-related quality of life in patients with systemic lupus erythematosus and primary Sjögren syndrome

Predictive Factors of De Novo Overactive Bladder after Artificial Urinary Sphincter Implantation in Men with Post-Prostatectomy Incontinence